Effect of Ginkgo biloba extract on experimental cardiac remodeling

BMC Complementary and Alternative Medicine

Xianchun Shen²  Lirong Wu³  Yini Xu²  Lingyun Fu²  Xingde Liu³  Zhenhua Luo¹  Wei Li² 

[1] Central laboratory, Guizhou Provincial People’s Hospital, Zhongshan East Road 83, Guiyang 550002, Guizhou, China;Key Laboratory of Optimal utilization of Natural Medicinal Resources, School of Pharmaceutic Science, Guizhou Medical University, Huaxi College Station, Guian New District 550025, Guizhou, China;Department of Cadiovascular Medicine, Affiliated Hospital of Guizhou Medical University, Beijing Road, , Guiyang 550004, Guizhou, China

关键词: Matrix metallopeptidase 9;    Matrix metallopeptidase 2;    Type I collagen;    TGF-β1;    Acute myocardial infarction;    Ginkgo biloba extract;   

Others  :  1222552
DOI  :  10.1186/s12906-015-0719-z

 received in 2015-02-04, accepted in 2015-06-11,  发布年份 2015

【 摘 要 】

Background

To investigate the ameliorated effects of an extract of Ginkgo biloba extract (GBE) on experimental cardiac remodeling in rats induced by acute cardiac infarction, and further explore the mechanism concentrated on myocardial type I collagen, transforming growth factor beta 1 (TGF-β1), matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9), and provide the experimentaldata for clinical application of GBE.

Methods

Rats were divided into five groups (n = 20) as following: sham operation group (group A), acute myocardial infarction model group (group B), acute myocardial infarction model + aspirin (10 mg/kg) treatment group (group C), acute myocardial infarction model + captopril (20 mg/kg) treatment group (group D) and acute myocardial infarction model + Ginkgo biloba extract (100 mg/kg) treatment group (group E). The rat acute myocardial infarction model was reproduced by ligaturing the left anterior descending artery excluding the sham operation group which did not ligation only completed the operational process. Each group was further subdivided into treatment regimens lasting 4 weeks and 8 weeks. Immunohistochemistry and real-time polymerase chain reaction (PCR) methods were used to detect the protein expression and mRNA transcriptional levels of rat myocardial TGF-β1, type I collagen, MMP-2 and MMP-9.

Results

Compared with group B, regardless of the length of treatment (4 or 8 weeks), the TGF-β1, MMP-2 and MMP-9 mRNA transcriptional levels, and the protein expression levels of type I collagen, MMP-2 and MMP-9 in groups D, C and E were significantly decreased (P < 0.01). Furthermore, the mRNA expression levels of TGF-β1 in groups D, C and E were significantly lower after 8 weeks compared to after 4 weeks (P < 0.01), as were the expression levels of type I collagen in groups D, C and E (P < 0.05). There was no statistically significant difference in the protein expression levels of MMP-2 and MMP-9 between groups E and C.

Conclusions

GBE could inhibit experimental rat myocardial remodeling after acute myocardial infarction via reduced transcription of TGF-β1, MMP-2 and MMP-9 genes and by the decreased expression of type I collagen, MMP-2 and MMP-9 proteins in myocardial cells.

【 授权许可】

   
2015 Li et al.

【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

Fig. 4.

【 参考文献 】

• [1]Muhlestein JB. Adverse left ventricular remodeling after acute myocardial infarction: is there a simple treatment that really works? Eur Heart J. 2014; 35:144-6.
• [2]Schuh A, Curaj A, Postea O, Kanzler I, Tuchscherer N, Liehn EA. Influence of inflammatory cells on local collagen production, collagen pattern and cardiac remodeling after myocardial infarction. Circulation. 2013;128:A13525.
• [3]Wei YJ, Huang YX, Shen Y, Zhang XL, Zhang H, Hu SS. Proteomic analysis reveals significant elevation of heart shock protein 70 in patients with chronic heart failure due to arrhythmogenic right ventricular cardiomyopathy. Mol Cell Biochem. 2009; 332:103-11.
• [4]Yokota T, Tomita H, Mori Y, Kudo T, Hiraga H, Suto N, et al. Imidapril and enalapril similarly inhibit plasma matrix metalloproteinase activities and attenuate left ventricular remodeling in patients with acute myocardial infarction. J Cardiovasc Pharm. 2014;63:528–32.
• [5]Ishii S, Inomata T, Ikeda Y, Nabeta T, Iwamoto M, Watanabe I, et al. Clinical significance of heart rate during acute decompensated heart failure to predict left ventricular reverse remodeling and prognosis in response to therapies in nonischemicdilated cardiomyopathy. Heart Vessels. 2014;29:88–96.
• [6]Liu XP, Luan JJ, Christopher EG. Comparison of the antioxidant activity amongst gigkobiloba extract and its main components. Chin Medicinal Mater. 2009; 32:736-40.
• [7]Ran K, Yang DL, Chang YT, Duan KM, Ou YW, Wang HP, et al. Ginkgo biloba extract postconditioning reduces myocardial ischemia reperfusion injury. Genet Mol Res. 2014;13:2703–8.
• [8]Qiao ZY, Huang JH, Ma JW, Xu YW, Xie J, Liu HJ, et al. Ginkgo biloba extract reducing myocardium cells apoptosis by regulating apoptotic related proteins expression in myocardium tissues. Mol Biol Rep. 2014;41:347–53.
• [9]Liu SQ, Yu JP, Chen HL, Luo HS, Chen SM, Yu HG. Therapeutic effects and molecular mechanisms of Ginkgo biloba extract on liver fibrosis in rats. Am J Chin Med. 2006; 34:99-114.
• [10]Liu HA, Bao YM, Wang XY, Zhang ZX. Cardio-Protection by Ginkgo biloba Extract 50 in Rats with Acute Myocardial Infarction is Related to Na + –Ca 2+ Exchanger. Am J Chin Med. 2013; 41:789-800.
• [11]Shen X, Yang Y, Xu Y, Xu L, Fang T. Protective effect of TGF-beta-Smads signal-based oxymatrine on myocardial fibrosis induced by acute myocardial infarction in rats. China J Chin Mater Medica. 2012; 37:632-6.
• [12]Jiang X, Ning Q, Wang J. Angiotensin II induced differentially expressed microRNAs in adult rat cardiac fibroblasts. J Physiol Sci. 2013; 63:31-8.
• [13]Hua Y, Zhang Y, Ceylan-Isik AF, Wold LE, Nunn JM, Ren J. Chronic Akt activation accentuates aging-induced cardiac hypertrophy and myocardial contractile dysfunction:role of autophagy. Basic Res Cardiol. 2011; 106:1173-91.
• [14]Li Q, Xu Y, Li X, Guo Y, Liu G. Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction:role of TGF-betal-TAK1. Toxicol Lett. 2012; 211:91-7.
• [15]Van den Borne SW, Isobe S, Verjans JW, Petrov A, Lovhaug D, Li P, et al. Molecular imaging of interstitial alteration in remodeling myocardium after myocardial infarction. J Am Coll Cardiol. 2008;52:2017–21.
• [16]Zhao XD, Dong N, Zhang MH, Man HT, Ma SL. Research progress of the regulatory effects of Ginkgo Biloba Extract on cell. Med Rev. 2014; 20:205-8.
• [17]Wang ZF, Wang NP, Harmouche S, Philip T, Pang XF, Bai F, et al. Postconditioning promotes the cardiac repair through balancing collagen degradation and synthesis after myocardial infarction in rats. Basic Res Cardiol. 2013;108:1–15.
• [18]Santibañez JF, Quintanilla M, Bernabeu C. TGF-β/TGF-β receptor system and its role in physiological and pathological conditions. Clin Sci. 2011; 121:233-51.
• [19]Skalicku HJ, Horak J, Aschermann M, Linhart A, Palecek T, Kobylka P. Myocardial infarctio, left ventricle remodeling and cellular therapy. Vnitr Lek. 2009; 55:37-44.
• [20]Vasiuk YA, Shkol’nik EL, Kudriakov ON, Kudriakov ON, Kulikov KG. Effect of therapy with trimetazidine modified release on quality of life of patients with stable effort abgina survivors after acute myocardial infarction results of PRIMA study. Kardiologiia. 2010; 50:45-9.
• [21]Mouquet F, Rousseau D, Domergue-Dupont V, Grynberg A, Liao R. Effects of trimetazidine, a partial inhibitor of fatty acid oxidation, on ventricular function and survival after myocardial infarction and reperfusion in the rat. Fund Clin Pharmacol. 2010; 24:469-76.
• [22]Shimizu N, Yoshiyama M, Takeuchi K, Hanatani A, Kim S, Omura T, et al. Doppler echocardiographic assessment And cardiac gene expression analysis of the left ventricle in myocardial infracted rats. Jpn Circ J. 1998;62:436–42.
• [23]Sutton MSJ, Pfeffer MA, Moye L, Plappert T, Rouleau JL, Lamas G, et al. Cardiovascular death and left ventricular remodeling two years after myocardial infarction baseline predictors and impact of long-term use of captopril: Information from the Survival and Ventricular Enlargement (SAVE) trial. Circulation. 1997;96:3294–9.
• [24]Okada M, Kosaka N, Hoshino Y, Yamawaki H, Hara Y. Effects of captopril and telmisartan on matrix metalloproteinase-2 and-9 expressions and development of left ventricular fibrosis induced by isoprenaline in rats. Biol Pharm Bull. 2010;33:1517–21.
• [25]Kalkman EAJ, van Suylen RJ, van Dijk JP, Saxena PR, Schoemaker RG. Chronic aspirin treatment affects collagen deposition in non-infarcted myocardium during remodeling after coronary artery ligation in the rat. J Mol Cell Cardiol. 1995; 27:2483-94.
• [26]Mulay SR, Gaikwad AB, Tikoo K. Combination of aspirin with telmisartan suppresses the augmented TGF-β/smadsignaling during the development of streptozotocin-induced type I diabetic nephropathy. Chem-Biol Interac. 2010; 185:137-42.
• [27]McIntosh Ambrose W, Salahuddin A, So S, Ng S, Ponce Márquez S, Takezawa T, et al. Collagen vitrigel membranes for the in vitro reconstruction of separate corneal epithelial, stromal, and endothelial cell layers. J Biomed Mater Res. 2009;90:818–31.
• [28]Mozet C, Martin R, Welt K, Fitzl G. Cardioprotective effect of EGB 761 on myocardial ultrastructure of young and old rat heart and antioxidant status during acute hypoxia. Aging Clin Exp Res. 2009; 21:14-21.